Vanguard Capital Management
PRAX icon

Vanguard Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Vanguard Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414M Buy
1,235,299
+13,355
+1% +$4.23M 0.01% 777
2026
Q1 		$394M Buy
+1,221,944
New +$378M 0.01% 749

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management's PRAX Position: Q2 2026 in Review

Vanguard Capital Management increased its Praxis Precision Medicines (PRAX) stake by 1.1% in Q2 2026, buying an estimated $4.23M and bringing the position to 1,235,299 shares worth $414M. The position accounts for 0.01% of the portfolio, ranked #777.

Vanguard Capital Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 281 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Vanguard Capital Management held 1,235,299 shares of Praxis Precision Medicines worth $414M as of Q2 2026.
  • Vanguard Capital Management bought 13,355 Praxis Precision Medicines shares in Q2 2026, an estimated $4.23M.
  • Praxis Precision Medicines made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #777 holding.
  • Vanguard Capital Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 281 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.